ISRCTN63412511已完成不适用
Effects of a three-month course of rosuvastatin in patients with Systemic Lupus Erythematosus
AstraZeneca (The Netherlands)0 个研究点目标入组 19 人开始时间: 2008年3月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with chronic, non-acute SLE
- •2. Greater than 18 years old, either sex
排除标准
- •1. Use of statins
- •2. Pregnancy
- •3. Raised liver enzymes
- •4. Recent (less than three months) major surgery or myocardial infarction
研究者
相似试验
已完成
3 期
Evaluation of the effects of Rosuvastatin in the treatment of patients with deep vein thrombosis(DVT)IRCT20150621022852N4Shahid Beheshti University of Medical Sciences50
招募中
2 期
Rosuvastatin in patients with moderate brain traumaModerate traumatic brain injury.Diffuse traumatic brain injuryS06.2IRCT20230627058603N2Esfahan University of Medical Sciences200
已完成
3 期
The assessment of effect of Rosuvastatin use in venous thromboembolismVenous thromboembolism includes deep vein thrombosis and pulmonary embolism.venous embolism and thrombosisCode I82IRCT20210416050990N1Shahid Beheshti University of Medical Sciences220
尚未招募
2 期
Role of lipid lowering drug in the treatment of rectal cancersCTRI/2018/11/016459Tata Memorial Hospital
招募中
3 期
A clinical trial to investigate the efficiency of rosuvastatin in acute cardiomyopathy induced anthracyclineCardiomyopathyIRCT2016121213090N3Vice chancellor for research of Mazandaran University of Medical Sciences80
